Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations ); please find enclosed herewith outcome of the board meeting held today i.e. May 29, 2025 along with Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2025.
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wockhardt Limited's board met on May 29, 2025 and approved the audited standalone and consolidated financial results for the fourth quarter and full financial year ended March 31, 2025. The company has submitted these results to the stock exchanges as required under SEBI listing rules. The actual financial figures and detailed results are enclosed with the filing but are not summarized in this announcement text. Shareholders will need to refer to the detailed results document for specific numbers on revenue, profit, expenses, and auditor observations.
This is a routine regulatory filing confirming the board has cleared the yearly and quarterly results — no direct stock price catalyst can be determined from this notice alone without the underlying numbers, which will likely be detailed in the separately filed results document.